There is currently no specific treatment for coronavirus, and several potential vaccines are now under clinical trials across the world.
A medical research team at Taibah University in Medina published a research paper in the American Journal of Public Health Research, where they discuss TaibUVID therapy. According to the research, TaibUVID is a novel evidence-based approach for treating COVID-19 patients. A single TaibUVID dose includes one small spoonful of Nigella Sativa oil mixed with 1 gram of ground anthemis hyalina mixed with one large spoonful of natural honey. This mixture is to be chewed in the mouth and swallowed orally for both COVID-19 contacts and patients. The paper claims that this concoction could minimize the COVID-19 fatalities. It also claimed that Nigella sativa oil could be used in treating pneumonia or bronchopneumonia in patients suffering from severe COVID-19 symptoms.
However, the World Health Organization (WHO) states that currently, there are no specific vaccines or treatments for COVID-19, and there are many ongoing clinical trials to develop a potential treatment for COVID-19. We conclude that TaibUVID cannot be used to treat COVID-19.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.